# Asahi Kasei and Bluestar study mPPE production in China

Asahi Kasei and Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for modified polyphenylene ether (mPPE) in China, including intermediates. A final investment decision is planned by March 2018.

- Type: Investment
- Announced: 2017-10-02
- Where: China, China
- Status: announced
- Products: modified polyphenylene ether (mPPE), 2,6-xylenol, polyphenylene ether (PPE)
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md), [Plastics and Polymers](https://endata.com/sectors/plastics-polymers.md)

## Companies

- [Asahi Kasei](https://endata.com/companies/8888.md) (partner)
- [Bluestar](https://endata.com/companies/27335.md) (partner)

## Sources

- [chemanager-online.com](https://chemanager-online.com/en/news/asahi-kasei-and-bluestar-studying-mppe), 2017-10-02: "Japan’s Asahi Kasei and China’s Bluestar, a ChemChina subsidiary, have agreed to study the economics of building production facilities for producing a modified polyphenylene ether (mPPE) in China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.